RA CAPITAL MANAGEMENT, L.P.
JANXRA CAPITAL MANAGEMENT, L.P. serves as director, 10 percent owner: at Janux Therapeutics, Inc. (JANX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
RA CAPITAL MANAGEMENT, L.P.'s Insider Trading at Phathom Pharmaceuticals, Inc. (PHAT)
Buys
0 · $0.00
Sells
1 · $31.06M
Total Shares Bought
0
Total Shares Sold
710,000
RA CAPITAL MANAGEMENT, L.P.'s Insider Trading at Werewolf Therapeutics, Inc. (HOWL)
Buys
1 · $27.44M
Sells
0 · $0.00
Total Shares Bought
1,715,000
Total Shares Sold
0
RA CAPITAL MANAGEMENT, L.P.'s Insider Trading at Solid Biosciences Inc. (SLDB)
Buys
1 · $12.69M
Sells
0 · $0.00
Total Shares Bought
2,206,685
Total Shares Sold
0
Showing 51–53 of 53
Related Insiders
EVNIN LUKE
Director
HOWLSell · Jul 8, 2026
GC Corp.
10 percent owner
ARTVBuy · May 28, 2026
Jennifer Bush
officer: COO, CLO, Compliance Officer
ARTVSell · May 19, 2026
Fred Aslan
President and CEO
ARTVSell · May 19, 2026
Subhashis Banerjee
officer: Chief Medical Officer
ARTVSell · May 19, 2026
Christopher Horan
officer: Chief Tech Operations Officer
ARTVSell · May 19, 2026
Heather Raymon
SVP, Research and Development
ARTVSell · May 19, 2026
GADICKE ANSBERT
Insider
HOWLSell · Dec 2, 2025